D-0011-2019 Class II Terminated
FDA drug recall D-0011-2019 was initiated by Jubilant Cadista Pharmaceuticals, Inc. on Oct 2, 2018 and is designated Class II. Reason for recall: Discoloration: Presence of dark discoloration or brown spots on the edges of the tablets. The recall status is terminated (terminated Feb 24, 2020). Affected quantity: 158,466 bottles.
Recall details
- Product Type
- Drugs
- Report Date
- Oct 17, 2018
- Initiation Date
- Oct 2, 2018
- Termination Date
- Feb 24, 2020
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 158,466 bottles
Product description
Pantoprazole Sodium Delayed-Release Tablets, USP, 40 mg*, 90-count bottle, Rx only, Manufactured by: Jubilant Generics Ltd., Roorkee - 247661, India; Marketed by: Jubilant Cadista Pharmaceuticals Inc., Salisbury, MD 21801; NDC 59746-284-90.
Reason for recall
Discoloration: Presence of dark discoloration or brown spots on the edges of the tablets.
Distribution pattern
Product was distributed Nationwide in the USA and Puerto Rico.
Code information
Lot #: PA26038A, Exp 04/19; PA26039A, PA26040A, PA26050A, Exp 05/19; PA26052A, Exp 06/19; PA26073A, Exp 07/19; PA217071A, PA217072A, PA217073B, PA217074B, Exp 06/20; PA217101A, Exp 08/20; and PA218023A, Exp 01/21.
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0011-2019
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026